Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rupert Bartsch

Showing results (31-40 of 228) with videos related to

Pageof 23
Sort By:
Biologics : Targets & Therapy|August 27, 2009
Trastuzumab in the management of early and advanced stage breast cancerRupert Bartsch, Catharina Wenzel, Guenther G Steger
The Lancet. Oncology|December 20, 2014
CDK4/6 inhibitors in luminal breast cancerMichael Gnant, Guenther G Steger, Rupert Bartsch
The Lancet. Oncology|August 15, 2015
Bevacizumab: no comeback in early breast cancer?Rupert Bartsch, Michael Gnant, Guenther G Steger
The Lancet. Oncology|December 28, 2020
Results from the FeDeriCa trial: are we reducing the burden of breast cancer treatment?Rupert Bartsch, Christoph Minichsdorfer, Cornelia Kolberg-Liedtke
Wiener Klinische Wochenschrift|July 31, 2025
Vanessa Castagnaviz, Anna Fenzl, Michael Gnant, et al.
Anticancer Research|August 5, 2006
Serum interleukin-6 levels in patients with gastric MALT lymphoma compared to gastric and pancreatic cancerRupert Bartsch, Stefan Woehrer, Markus Raderer, et al.
Memo|May 9, 2020
Circumnavigating the challenges of COVID-19 in oncologyThorsten Fuereder, Eberhard Gunsilius, Rupert Bartsch, et al.
Wiener Klinische Wochenschrift|September 22, 2025
Vanessa Castagnaviz, Anna Fenzl, Michael Gnant, et al.
Breast Care (Basel, Switzerland)|December 14, 2011
Opinions on the ASCO 2011 Annual MeetingRupert Bartsch, Peter C Dubsky, Sibylle Loibl, et al.
Breast Care (Basel, Switzerland)|July 23, 2011
Breast Cancer: Rank Ligand InhibitionRupert Bartsch, Guenther G Steger, Michael Gnant, et al.
Pageof 23

Showing results (31-40 of 228) with videos related to

Sort By:
Pageof 23
Biologics : Targets & Therapy|August 27, 2009
Trastuzumab in the management of early and advanced stage breast cancerRupert Bartsch, Catharina Wenzel, Guenther G Steger
The Lancet. Oncology|December 20, 2014
CDK4/6 inhibitors in luminal breast cancerMichael Gnant, Guenther G Steger, Rupert Bartsch
The Lancet. Oncology|August 15, 2015
Bevacizumab: no comeback in early breast cancer?Rupert Bartsch, Michael Gnant, Guenther G Steger
The Lancet. Oncology|December 28, 2020
Results from the FeDeriCa trial: are we reducing the burden of breast cancer treatment?Rupert Bartsch, Christoph Minichsdorfer, Cornelia Kolberg-Liedtke
Wiener Klinische Wochenschrift|July 31, 2025
Vanessa Castagnaviz, Anna Fenzl, Michael Gnant, et al.
Anticancer Research|August 5, 2006
Serum interleukin-6 levels in patients with gastric MALT lymphoma compared to gastric and pancreatic cancerRupert Bartsch, Stefan Woehrer, Markus Raderer, et al.
Memo|May 9, 2020
Circumnavigating the challenges of COVID-19 in oncologyThorsten Fuereder, Eberhard Gunsilius, Rupert Bartsch, et al.
Wiener Klinische Wochenschrift|September 22, 2025
Vanessa Castagnaviz, Anna Fenzl, Michael Gnant, et al.
Breast Care (Basel, Switzerland)|December 14, 2011
Opinions on the ASCO 2011 Annual MeetingRupert Bartsch, Peter C Dubsky, Sibylle Loibl, et al.
Breast Care (Basel, Switzerland)|July 23, 2011
Breast Cancer: Rank Ligand InhibitionRupert Bartsch, Guenther G Steger, Michael Gnant, et al.
Pageof 23